Dr. Przybyl received a joint Ph.D. degree in biomedical sciences from KU Leuven, Belgium and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. Her doctoral studies focused on identifying new prognostic and predictive markers for soft tissue sarcoma. In 2021, Dr. Przybyl joined the Department of Surgery of the McGill University and the Cancer Research Program of the Research Institute of the McGill University Health Centre (RI-MUHC) to pursue research program focused on the clinical applications of liquid biopsies and metabolic reprogramming in sarcoma. Dr. Przybyl is also an Associate Member in the Department of Pathology of the McGill University.
The research projects in the laboratory of Dr. Przybyl are focused on: 1) development of liquid biopsy (circulating tumor DNA) assays for patients with soft tissue tumors, 2) metabolic reprogramming in selected types of soft tissue tumors, and 3) multi-omic profiling of soft tissue tumors to identify new diagnostic markers and therapeutic targets in these tumors.